Lepu Biopharma Revenue

In the year 2025, Lepu Biopharma had annual revenue of 934.87M CNY with 154.18% growth. Lepu Biopharma had revenue of 468.93M in the half year ending December 31, 2025, with 553.11% growth.

Revenue

934.87M CNY

Revenue Growth

+154.18%

P/S Ratio

9.37

Revenue / Employee

1.71M CNY

Employees

546

Market Cap

9.74B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	934.87M	567.08M	154.18%
Dec 31, 2024	367.79M	142.44M	63.21%
Dec 31, 2023	225.35M	209.78M	1,347.16%
Dec 31, 2022	15.57M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Alphamab Oncology	630.11M
Shanghai Haohai Biological Technology	2.73B
Abbisko Cayman	681.17M
HBM Holdings	1.23B
Everest Medicines	1.90B
CARsgen Therapeutics Holdings	139.84M
Guangzhou Innogen Pharmaceutical Group	146.34M
CK Life Sciences Int'l., (Holdings)	5.41B

Revenue Rankings